Evidence map›Paper›PMID 25660836›Full record

ArticleJACC. Heart failure2015

Intravenous fluids in acute decompensated heart failure.

Behnood Bikdeli, Kelly M Strait, Kumar Dharmarajan, Shu-Xia Li, Purav Mody, Chohreh Partovian, Steven G Coca, Nancy Kim, Leora I Horwitz, Jeffrey M Testani and 1 more

Open access · greenAbstract read
In one paragraph

Article in JACC. Heart failure, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Medical management of pediatric heart failure.Cardiovascular diagnosis and therapy · 2021 · on this map
    Review
  7. Article
  8. Review
  9. Iatrogenic Decompensated Heart Failure.Current heart failure reports · 2020
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Acute kidney injury and 'nephrotoxins': mind your language.Clinical medicine (London, England) · 2018
    Review
  15. Article
  16. Learning to prescribe intravenous fluids: A scoping review.Perspectives on medical education · 2017
    Article
  17. Observational
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Behnood BikdeliCenter for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
Kelly M StraitCenter for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut.
Kumar DharmarajanCenter for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut; Division of Cardiology, Columbia University Medical Center, New York, New York.
Shu-Xia LiCenter for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut.
Purav ModyCenter for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut; Department of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.
Chohreh PartovianSection of General Internal Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
Steven G CocaSection of Nephrology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
Nancy KimCenter for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut; Section of General Internal Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
Leora I HorwitzCenter for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut; Section of General Internal Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
Jeffrey M TestaniSection of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
Harlan M KrumholzCenter for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, Connecticut; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut; Robert Wood Johnson Foundation Clinical Scholars Program, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut; Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut. Electronic address: harlan.krumholz@yale.edu.
Yale New Haven Hospital · USYale University · US

Funding

YALE UNIVERSITY CLINICAL AND TRANSLATIONAL SCIENCE AWARD PROGRAMUL1RR024139 · NCRR · YALE UNIVERSITY · PI SHERWIN, ROBERT S · 2006 to 2011
$56.8M
POSTDOCTORAL TRAINING IN CARDIOVASCULAR DISEASET32HL007854 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Marwah Abdalla, Michael Argenziano · 1996 to 2026
$14.7M
Center for Cardiovascular Outcomes Research at Yale UniversityU01HL105270 · NHLBI · YALE UNIVERSITY · PI CURTIS, JEPTHA PELHAM, KRUMHOLZ, HARLAN MARC · 2010 to 2013
$5.8M
Cardio-renal phenotype and prognosis in chronic heart failureK23HL114868 · NHLBI · YALE UNIVERSITY · PI TESTANI, JEFFREY M · 2012 to 2017
$845k
Geriatric Conditions and Readmission after Acute Myocardial InfarctionK23AG048331 · NIA · YALE UNIVERSITY · PI DHARMARAJAN, KUMAR · 2014 to 2017
$692k
Heart Failure Readmissions in Older Adults: A Systems PerspectiveK08AG038336 · NIA · YALE UNIVERSITY · PI HORWITZ, LEORA · 2010 to 2013
$648k
NCRR NIH HHS UL1 RR024139NCRR NIH HHS UL1 RR024139-06S1NHLBI NIH HHS HL007854NHLBI NIH HHS K23 HL114868NHLBI NIH HHS T32 HL007854NHLBI NIH HHS U01 HL105270NHLBI NIH HHS U01 HL105270-05NIA NIH HHS K08 AG038336NIA NIH HHS K23 AG048331
6 · The paper itself

Abstract

objectivesThis study sought to determine the use of intravenous fluids in the early care of patients with acute decompensated heart failure (HF) who are treated with loop diuretics.

backgroundIntravenous fluids are routinely provided to many hospitalized patients.

methodsWe conducted a retrospective cohort study of patients admitted with HF to 346 hospitals from 2009 to 2010. We assessed the use of intravenous fluids during the first 2 days of hospitalization. We determined the frequency of adverse in-hospital outcomes. We assessed variation in the use of intravenous fluids across hospitals and patient groups.

resultsAmong 131,430 hospitalizations for HF, 13,806 (11%) were in patients treated with intravenous fluids during the first 2 days. The median volume of administered fluid was 1,000 ml (interquartile range: 1,000 to 2,000 ml), and the most commonly used fluids were normal saline (80%) and half-normal saline (12%). Demographic characteristics and comorbidities were similar in hospitalizations in which patients did and did not receive fluids. Patients who were treated with intravenous fluids had higher rates of subsequent critical care admission (5.7% vs. 3.8%; p < 0.0001), intubation (1.4% vs. 1.0%; p = 0.0012), renal replacement therapy (0.6% vs. 0.3%; p < 0.0001), and hospital death (3.3% vs. 1.8%; p < 0.0001) compared with those who received only diuretics. The proportion of hospitalizations that used fluid treatment varied widely across hospitals (range: 0% to 71%; median: 12.5%).

conclusionsMany patients who are hospitalized with HF and receive diuretics also receive intravenous fluids during their early inpatient care, and the proportion varies among hospitals. Such practice is associated with worse outcomes and warrants further investigation.

Indexed as

Fluid TherapyAdolescentAdultAgedAged, 80 and overCohort StudiesDatabases, FactualFemaleHeart FailureHospitalizationHospital MortalityHumansInfusions, IntravenousIntensive Care UnitsIntubation, IntratrachealIsotonic SolutionsIsotonic SolutionsRinger's SolutionSaline Solution, HypertonicSodium Potassium Chloride Symporter Inhibitorsdiureticsheart failureintravenous fluids

Identifiers

PMID25660836
PMCPMC4438991
OpenAlexW1972880207

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.